FilingReader Intelligence
American Vietnamese Biotech revenue plunges 87% in Q2
July 31, 2025 at 06:01 PM UTC•By FilingReader AI
American Vietnamese Biotech reported revenue fell 87% to VND 2.98 billion in Q2 2025, down from VND 22.16 billion in the same period last year.
The Ho Chi Minh City-based medical equipment and testing chemicals company posted a net loss of VND 23.53 billion, though this was smaller than the VND 107.05 billion loss recorded in Q2 2024.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
HNX:AMV•Hanoi Stock Exchange
News Alerts
Get instant email alerts when American Vietnamese Biotech Incorporation publishes news
Free account required • Unsubscribe anytime